BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25213764)

  • 1. Genetic polymorphisms of inflammatory response gene TNF-α and its influence on sporadic pancreatic neuroendocrine tumors predisposition risk.
    Karakaxas D; Gazouli M; Coker A; Agalianos C; Papanikolaou IS; Patapis P; Liakakos T; Dervenis C
    Med Oncol; 2014 Oct; 31(10):241. PubMed ID: 25213764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic Neuroendocrine Tumors and Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Systematic Review.
    Manuel-Vazquez A; Ramia JM; Latorre-Fragua R; Valle-Rubio A; Arteaga-Peralta V; Ramiro-Pérez C; de la Plaza-Llamas R
    Pancreas; 2018; 47(5):551-555. PubMed ID: 29683974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep sequencing of cancer-related genes revealed GNAS mutations to be associated with intraductal papillary mucinous neoplasms and its main pancreatic duct dilation.
    Takano S; Fukasawa M; Maekawa S; Kadokura M; Miura M; Shindo H; Takahashi E; Sato T; Enomoto N
    PLoS One; 2014; 9(6):e98718. PubMed ID: 24897499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 1β gene single-nucleotide polymorphisms and susceptibility to pancreatic neuroendocrine tumors.
    Cigrovski Berković M; Catela Ivković T; Marout J; Zjačić-Rotkvić V; Kapitanović S
    DNA Cell Biol; 2012 Apr; 31(4):531-6. PubMed ID: 21988351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma.
    Duell EJ; Casella DP; Burk RD; Kelsey KT; Holly EA
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):726-31. PubMed ID: 16614115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCL9L expression in pancreatic neoplasia with a focus on SPN: a possible explanation for the enigma of the benign neoplasia.
    Hallas C; Phillipp J; Domanowsky L; Kah B; Tiemann K
    BMC Cancer; 2016 Aug; 16():648. PubMed ID: 27539223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF-alpha promoter single nucleotide polymorphisms in gastroenteropancreatic neuroendocrine tumors.
    Berković M; Cacev T; Zjacić-Rotkvić V; Kapitanović S
    Neuroendocrinology; 2006; 84(5):346-52. PubMed ID: 17164537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinction of Invasive Carcinoma Derived From Intraductal Papillary Mucinous Neoplasms From Concomitant Ductal Adenocarcinoma of the Pancreas Using Molecular Biomarkers.
    Tamura K; Ohtsuka T; Date K; Fujimoto T; Matsunaga T; Kimura H; Watanabe Y; Miyazaki T; Ohuchida K; Takahata S; Ishigami K; Oda Y; Mizumoto K; Nakamura M; Tanaka M
    Pancreas; 2016 Jul; 45(6):826-35. PubMed ID: 26646266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synchronous intraductal papillary mucinous neoplasm and a pancreatic neuroendocrine tumor: more than a coincidence?
    Costa JM; Carvalho S; Soares JB
    Rev Esp Enferm Dig; 2017 Sep; 109(9):663-635. PubMed ID: 28724304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between genetic polymorphisms in long non-coding RNAs and pancreatic cancer risk.
    Moschovis D; Vasilaki E; Tzouvala M; Karamanolis G; Katifelis H; Legaki E; Vezakis A; Aravantinos G; Gazouli M
    Cancer Biomark; 2019; 24(1):117-123. PubMed ID: 30475759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sonic hedgehog is an early developmental marker of intraductal papillary mucinous neoplasms: clinical implications of mRNA levels in pancreatic juice.
    Ohuchida K; Mizumoto K; Fujita H; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    J Pathol; 2006 Sep; 210(1):42-8. PubMed ID: 16794990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Hot-Spot Mutations in Circulating Cell-Free DNA From Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas.
    Berger AW; Schwerdel D; Costa IG; Hackert T; Strobel O; Lam S; Barth TF; Schröppel B; Meining A; Büchler MW; Zenke M; Hermann PC; Seufferlein T; Kleger A
    Gastroenterology; 2016 Aug; 151(2):267-70. PubMed ID: 27343369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal papillary mucinous neoplasms.
    Yu J; Sadakari Y; Shindo K; Suenaga M; Brant A; Almario JAN; Borges M; Barkley T; Fesharakizadeh S; Ford M; Hruban RH; Shin EJ; Lennon AM; Canto MI; Goggins M
    Gut; 2017 Sep; 66(9):1677-1687. PubMed ID: 27432539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of polymorphisms in EGF, EGFR and HER2 genes in pancreatic neuroendocrine tumors (PNETs).
    Marinović S; Cigrovski Berković M; Zjačić-Rotkvić V; Kapitanović S
    Cancer Genet; 2022 Aug; 266-267():44-50. PubMed ID: 35777127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma.
    Karmazanovsky G; Belousova E; Schima W; Glotov A; Kalinin D; Kriger A
    Eur J Radiol; 2019 Jan; 110():66-73. PubMed ID: 30599875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms of interleukin 1β gene and sporadic pancreatic neuroendocrine tumors susceptibility.
    Karakaxas D; Sioziou A; Aravantinos G; Coker A; Papanikolaou IS; Liakakos T; Dervenis C; Gazouli M
    World J Gastrointest Oncol; 2016 Jun; 8(6):520-5. PubMed ID: 27326321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between hyperechogenic pancreas and pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasms.
    Mandai K; Uno K; Nakase K; Kawamura T; Yasuda K
    J Med Ultrason (2001); 2019 Oct; 46(4):435-439. PubMed ID: 31069577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.
    Ideno N; Ohtsuka T; Kono H; Fujiwara K; Oda Y; Aishima S; Ito T; Ishigami K; Tokunaga S; Ohuchida K; Takahata S; Nakamura M; Mizumoto K; Tanaka M
    Ann Surg; 2013 Jul; 258(1):141-51. PubMed ID: 23532108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Risk of Malignancy in Branch-Duct Intraductal Papillary Mucinous Neoplasms.
    Oyama H; Tada M; Takagi K; Tateishi K; Hamada T; Nakai Y; Hakuta R; Ijichi H; Ishigaki K; Kanai S; Kogure H; Mizuno S; Saito K; Saito T; Sato T; Suzuki T; Takahara N; Morishita Y; Arita J; Hasegawa K; Tanaka M; Fukayama M; Koike K
    Gastroenterology; 2020 Jan; 158(1):226-237.e5. PubMed ID: 31473224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraductal papillary mucinous neoplasms of the pancreas with concurrent pancreatic and periampullary neoplasms.
    Sahora K; Crippa S; Zamboni G; Ferrone C; Warshaw AL; Lillemoe K; Mino-Kenudson M; Falconi M; Fernandez-del Castillo C
    Eur J Surg Oncol; 2016 Feb; 42(2):197-204. PubMed ID: 26687069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.